By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known
By Ron Mitchell The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient." Furosemide, commonly known as Salix or Lasix, is a widely-used anti-diuretic medication. In a release, the Kentucky Horsemen's Benevolent and Protective Association said the 6-2 vote
By Jeremy Balan The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding the potential employment of third-party furosemide administration in the state, but any change in procedures still likely won't occur until 2016. After the CHRB sent a proposal on third-party administration of furosemide, commonly known as
By Patrick Bartley In an unprecedented move on Monday, Racing NSW Stewards released a 36-page document detailing the reasons behind the guilty findings in the long- running Sam Kavanagh Midsummer Sun cobalt inquiry. In this inquiry Kavanagh and five other individuals faced 54 separate charges and were found guilty on 51 charges. The publication of
Press Release The New York Thoroughbred Horsemen’s Association (NYTHA) today announced its commitment to acquire state-of-the-art testing equipment for the New York Equine Drug Testing and Research Program at Morrisville State College. The new equipment, a triple quadrupole mass spectrometer, will be used to screen for new drugs that are alleged to be used in
Racing Australia - Media Release Racing Australia has today announced a ban on injections One Clear Day before races and official trials from 1 October, 2015. The ban extends to blood tests, vitamin injections and all other injections of any kind. Racing Australia believes there are compelling reasons for the introduction of a new rule
On Monday, August 31, the Ontario Racing Commission issued a Notice to the Industry stating that official veterinarians will be conducting enhanced examinations of horses entered into upcoming premier events, starting with this coming weekend’s stakes action at Mohawk Racetrack. The notice states that trainers with entries in the Metro Pace and the Canadian Pacing
By Tom LaMarra The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks. The board of directors met Aug. 29 and approved the measure, the CTT said in a release. The organization also said it supports third-party
Press Release The Indiana Horse Racing Commission reports no violations of its cobalt regulation midway through the 120 day race meet at Indiana Grand. After 60 days of racing (through July 31, 2015), all of the 221 samples tested were beneath the of 25 ppb (parts per billion) threshold. The average concentration was 3.65 ppb
All horses competing at AQHA shows must be clear of clenbuterol on or before November 1. Beginning November 1, 2015, clenbuterol will be considered a forbidden drug per AQHA Rule VIO401. Earlier this year, positive drug tests for detection of clenbuterol in American Quarter Horse racehorses resulted in significant penalties. As previously announced April 24,
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
